This study found that injecting growth factor concentrates into the scalp of five patients with androgenic alopecia led to notable improvements in hair density and quality over eight weeks, with patients reporting satisfaction and minimal side effects.
February 2024 in “Cosmoderma” This review discusses the use of low-dose oral minoxidil for patterned hair loss and reports it may offer improved compliance and safety compared to topical minoxidil, but provides no new clinical findings.
1 citations
,
August 2022 in “JAAD case reports” This article discusses the patterns and variants of alopecia areata, including the rare sisaipho, but reports no new research findings.
8 citations
,
October 2015 in “PubMed” Recent Phase III trials reported that once daily 5% minoxidil foam significantly increased hair count in women with female pattern hair loss and was shown to be as effective as twice daily 2% minoxidil solution.
May 2015 in “Journal of The American Academy of Dermatology” 5% minoxidil foam helps women with thinning hair.
1 citations
,
September 2002 in “PubMed” This study found that using a topical 2% minoxidil solution for 6-12 months may reduce hair loss and improve hair root conditions in some women with androgenic alopecia.
127 citations
,
July 1996 in “Journal of The American Academy of Dermatology” This study found that in women undergoing chemotherapy after breast surgery, topical minoxidil significantly shortened the duration of hair loss compared to a placebo without significant side effects.
36 citations
,
January 1991 in “PubMed” In this pilot study, 2% topical Minoxidil showed no benefit in preventing hair loss during chemotherapy for gynecologic cancers, although it was non-toxic.
